NBIX
Neurocrine Biosciences Inc
138.40$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.23 | 0.17 | 1.83 | 4.73 | 8.23 | 10.69 | 11.58 | 15.05 | 18.68 | 22.71 | 27.91 | |
| 0.19 | 0.40 | 0.41 | 0.01 | 0.05 | 0.08 | 0.10 | 0.15 | 0.23 | 0.39 | 0.33 | 0.51 | |
| -0.19 | 0.23 | 0.17 | 1.82 | 4.68 | 8.16 | 10.59 | 11.43 | 14.82 | 18.29 | 22.38 | 27.40 | |
| 0.62 | 0.96 | 1.09 | 1.04 | 1.68 | 2.09 | 2.81 | 3.35 | 4.69 | 5.59 | 7.05 | 9.91 | |
| 0.24 | 0.38 | 0.79 | 1.93 | 2.61 | 3.70 | 4.43 | 5.96 | 7.61 | 8.43 | 7.87 | 11.28 | |
| 0.86 | 1.35 | 1.87 | 3.31 | 4.29 | 7.40 | 8.92 | 10.39 | 12.30 | 15.81 | 16.88 | 21.36 | |
| -0.86 | -1.11 | -1.70 | -1.49 | 0.39 | 0.76 | 1.67 | 1.05 | 2.52 | 2.48 | 5.50 | 6.04 | |
| 0.00 | 0.00 | 0.00 | 0.22 | 0.32 | 0.33 | 0.34 | 0.26 | 0.07 | 0.05 | 1.22 | – | |
| -0.81 | -1.05 | -1.63 | -1.62 | 0.23 | 0.49 | 1.09 | 1.04 | 2.16 | 3.29 | 4.69 | 6.88 | |
| -0.06 | -0.07 | -0.09 | 0.19 | 0.01 | 0.10 | -3.07 | 0.12 | 0.60 | 0.82 | 1.40 | 2.21 | |
| -0.81 | -1.05 | -1.63 | -1.62 | 0.22 | 0.39 | 4.16 | 0.92 | 1.56 | 2.47 | 3.29 | 4.67 | |
| -0.85 | -1.04 | -1.61 | -1.37 | 0.43 | 0.90 | 1.51 | 1.41 | 2.68 | 4.12 | 6.17 | 6.50 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.